DTL
XERS icon

Dynamic Technology Lab’s Xeris Biopharma Holdings XERS Stock Holding History

Dynamic Technology Lab’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,200
Closed -$135K – 1211
2025
Q4 		$135K Buy
+17,200
New +$135K 0.03% 655
2024
Q2 		– Sell
-68,849
Closed -$153K – 1449
2024
Q1 		$153K Buy
+68,849
New +$178K 0.02% 942
2021
Q3 		– Sell
-18,350
Closed -$75K – 1517
2021
Q2 		$75K Sell
18,350
-4,236
-19% -$16.2K 0.01% 1057
2021
Q1 		$102K Buy
+22,586
New +$122K 0.01% 1035

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dynamic Technology Lab's XERS Position: Q1 2026 in Review

Dynamic Technology Lab sold out of Xeris Biopharma Holdings (XERS) in Q1 2026, closing a stake of 17,200 shares — an estimated $135K sold.

Dynamic Technology Lab first reported a position in XERS in Q1 2021 and held it in 4 quarters. The position peaked at $153K in Q1 2024. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Dynamic Technology Lab reported no remaining Xeris Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 17,200 Xeris Biopharma Holdings shares in Q1 2026, an estimated $135K.
  • Dynamic Technology Lab first reported a position in Xeris Biopharma Holdings in Q1 2021 and held it in 4 quarters.
  • Dynamic Technology Lab's Xeris Biopharma Holdings position peaked at $153K in Q1 2024.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.